In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 21, 2017
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Antipsychotic Agents (MeSH)
- Delirium (MeSH)
- Double-Blind Method (MeSH)
- Haloperidol (MeSH)
- Humans (MeSH)
- Palliative Care (MeSH)
- Risperidone (MeSH)
published in
- ACP journal club Journal